Skip to main content
Journal of the Endocrine Society logoLink to Journal of the Endocrine Society
. 2019 Jul 25;3(9):1715–1726. doi: 10.1210/js.2019-00201

Urinary Bisphenols and Obesity Prevalence Among U.S. Children and Adolescents

Melanie H Jacobson 1,, Miriam Woodward 1, Wei Bao 2,3,4,5,6, Buyun Liu 2, Leonardo Trasande 1,7,8,9
PMCID: PMC6735733  PMID: 31528831

Abstract

Bisphenol A (BPA) has been recognized as an endocrine disrupting chemical and identified as an obesogen. Although once ubiquitous, human exposure to BPA has been declining owing to its substitution with other bisphenols. Two structurally similar substitutes, bisphenol S (BPS) and bisphenol F (BPF), have raised similar concerns, although fewer studies have been conducted on these newer derivatives. We used data from the US National Health and Nutrition Examination Surveys from 2013 to 2016 to evaluate associations between BPA, BPS, and BPF and body mass outcomes among children and adolescents aged 6 to 19 years. Concentrations of BPA, BPS, and BPF were measured in spot urine samples using HPLC with tandem mass spectrometry. General obesity was defined as ≥95th percentile of the age- and sex-standardized body mass index (BMI) z-scores according to the 2000 US norms. Abdominal obesity was defined as a waist circumference/height ratio of ≥0.5. BPA, BPS, and BPF were detected in 97.5%, 87.8%, and 55.2% of urine samples, respectively. Log-transformed urinary BPS concentrations were associated with an increased prevalence of general obesity (OR, 1.16; 95% CI, 1.02 to 1.32) and abdominal obesity (OR, 1.13; 95% CI, 1.02 to 1.27). BPF detection (vs not detected) was associated with an increased prevalence of abdominal obesity (OR, 1.29; 95% CI, 1.01 to 1.64) and continuous BMI z-score (β = 0.10; 95% CI, 0.01 to 0.20). BPA and total bisphenols were not statistically significantly associated with general obesity, abdominal obesity, or any body mass outcome. These results suggest that BPA substitute chemicals are correlated with obesity in contemporary children.

Keywords: bisphenol A, bisphenol S, bisphenol F, bisphenol A replacements, obesity, childhood obesity


Bisphenol A (BPA) is one of the best known synthetic chemical obesogens [1, 2]. It enlarges adipocytes and enhances differentiation from mesenchymal cells to adipocytes [3], inhibits adiponectin function [4], and is a synthetic estrogen and, thereby, can have sex-specific effects on body mass [5]. Although longitudinal cohort studies have not yielded identical results, the totality of laboratory and human evidence has suggested substantial probability of causation [6]. Increasing concern about obesogenic and other adverse effects of BPA have precipitated the substitution of BPA with 1 of the 40 structurally similar bisphenols currently in use [7]. Although tissue and animal studies of the replacements are lacking, two common analogs, bisphenol S (BPS) and bisphenol F (BPF), have shown estrogenic activity [8, 9]. Furthermore, BPS has been shown to promote preadipocyte differentiation [10], raising the possibility that these BPA replacements can induce the same obesogenic effects in humans.

As a step toward examining this question, we examined the cross-sectional relationships of urinary BPA, BPS, and BPF and body mass outcomes among children in the US National Health and Nutrition Examination Surveys (NHANES) from 2013 to 2016. The present analysis reprises work we performed using the NHANES from 2003 to 2008 [11] and is supported by recent work using NHANES from 2013 to 2014 identifying associations of urinary BPF with obesity in children and adolescents [12].

1. Materials and Methods

A. Study Population

NHANES is a nationally representative survey conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention that collects and releases data continuously over time in 2-year cycles [13]. The present study combined data from the 2013 to 2014 and 2015 to 2016 cycles to provide more statistically reliable estimates. Data from the questionnaire, laboratory, diet, and physical examination components of the NHANES were used for the present study. The study population was restricted to those aged 6 to 19 years, which resulted in 1831 children and adolescents.

B. Measures

B-1. Bisphenol compounds

Concentrations of BPA, BPS, and BPF were measured in spot urine samples using HPLC with tandem mass spectrometry. Further details on the analytical methods have been previously reported [14]. BPA, BPS, and BPF were detected in 97.5%, 87.8%, and 55.2% of samples, respectively (weighted proportions). For BPA and BPS, concentrations less than the limit of detection (LOD) (0.2 and 0.1 ng/mL, respectively) were substituted by the LOD divided by the square root of two. However, because BPF was only detected in just over one half of the samples, substitution was not conducted, and it was analyzed as a dichotomous variable, as less than and greater than the LOD (0.2 ng/mL). The total bisphenol concentrations were calculated by summing the concentrations of BPA, BPS, and BPF. When constructing the total bisphenol concentrations, BPF measures less than the LOD were imputed by the LOD divided by the square root of two.

B-2. Body mass outcomes

Although the primary outcome of interest was obesity, we also examined overweight, severe obesity, and body mass index (BMI) z-scores as a continuous measure and a as measure of abdominal obesity. As a part of the NHANES anthropometry protocol, trained health technicians measured the height, weight, and waist circumference using standardized examination procedures [15]. The BMI was calculated from measured height and weight values as the weight in kilograms divided by the height in meters squared (kg/m2). Because the BMI changes rapidly in childhood and by age and sex, the BMIs were standardized to age- and sex-adjusted z-scores according to the 2000 US norms [16, 17]. Overweight and obesity (hereafter referred to as general obesity) were defined by the 85th and 95th percentiles of the BMI z-scores, respectively [18]. Severe obesity was defined as >120% of the 95th percentile of the BMI z-scores or a BMI of ≥35 kg/m2, whichever was lower [19]. The BMI z-score was also examined as a continuous variable. Abdominal obesity was defined as a waist circumference/height ratio ≥0.5 [12, 20].

B-3. Covariates

Data from the two cycles (2013 to 2014 and 2015 to 2016) were combined using the appropriate weighting guidelines [21]. The demographic variables included sex, age, race/ethnicity, education level of the head of household, and the ratio of family income to poverty [or the poverty/income ratio (PIR)]. Behavioral factors were also examined. These included the time spent watching television, caloric intake determined from 24-hour dietary recall interviews, and tobacco smoke exposure. Tobacco smoke exposure was assessed using a composite variable owing to a disparity in the NHANES data availability from the 2013 to 2014 and 2015 to 2016 cycles. In 2013 to 2014, smoke exposure was determined from serum cotinine concentrations (≥2 ng/mL considered as exposure) and in 2015 to 2016, was based on one or more smokers in the child’s household or ever having smoked themselves if the child was ≥12 years old.

C. Statistical Analysis

Statistical analyses were based on our previously reported work on BPA and obesity [11]. First, we explored the distribution of bisphenol exposure in the study population by computing the geometric mean values of BPA and BPS for each covariate stratum. For BPF, we examined the study population characteristics across strata of BPF detection (i.e., less than and greater than the LOD). Differences across strata for BPA and BPS were evaluated using Mann-Whitney U tests for dichotomous variables and Kruskal-Wallis H tests for variables with two or more categories and for BPF detection using χ2 tests.

The associations between bisphenol compounds and general obesity were tested by fitting three sets of logistic regression models. First, models were fit, controlling only for urinary creatinine. Second, to assess the potential for heterogeneity in this association, models were stratified by the demographic and behavioral characteristics examined. Finally, fully adjusted models were fit, controlling for the following covariates: urinary creatinine, sex, race/ethnicity, age, head of household education, PIR, serum cotinine exposure and/or smoking, caloric intake, and time spent watching television. Finally, additional multivariable logistic regression models were fit for the overweight, severe obesity, and abdominal obesity outcomes, and a multivariable linear regression model was fit for the BMI z-score outcome, all controlling for these same covariates. In all models, BPA, BPS, and total bisphenols were assessed as natural log-transformed continuous variables. However, because of its lower detection frequency (55.2%), BPF was assessed as dichotomized as less than and greater than the LOD. In subsequent sensitivity analyses, all models were fit again with BPA, BPS, and total bisphenol concentrations, parameterized in quartiles to assess the potential for nonmonotonic associations. All statistical analyses were conducted using Stata, version 14 (StataCorp, College Station, TX). All analyses accounted for the complex survey sampling according to the NHANES analytic guidelines [22] and were appropriately weighted. All statistical tests were two-sided and α of 0.05.

2. Results

The median concentrations of BPA, BPS, and BPF were 1.3 ng/mL (25th percentile, 0.7 ng/mL; 75th percentile, 2.3 ng/mL), 0.4 ng/mL (25th percentile, 0.2 ng/mL; 75th percentile, 0.8 ng/mL), and 0.2 ng/mL (25th percentile, LOD or less; 75th percentile, 0.7 ng/mL), respectively. Age and sex were not significantly associated with BPA or BPS; however, those with detectable BPF concentrations were more likely to be adolescents (age, 12 to 19 years; 59.5%) vs children (age, 6 to 11 years) compared with those without detectable BPF concentrations (51.6%; P = 0.02; Table 1). The BPA and BPS concentrations were inversely associated with PIR, such that those with a low PIR (i.e., lower income) tended to have greater BPA and BPS concentrations compared with those with a greater PIR. This trend was similar for head of household education and BPS. Finally, BPA, BPS, and BPF exposure varied with race/ethnicity but in different patterns. For example, compared with all other race/ethnicities, non-Hispanic blacks had the greatest concentrations of BPA, and non-Hispanic blacks and Hispanics had the greatest concentrations of BPS. Finally, those with detectable BPF were more likely to be non-Hispanic whites and blacks compared with those without detectable BPF.

Table 1.

Study Population Characteristics in Total Sample Stratified by BPA and BPS Concentrations and BPF Detection, NHANES from 2013 to 2016

Characteristic Totala (n = 1831), n (%) BPA (ng/mL) BPS (ng/mL) BPF Detection, % (SE)
GM GSE P Valueb GM GSE P Valueb Yes (n = 948) No (n = 883) P Valuec
Sex
 Male 937 (50.76) 1.29 0.06 0.36 0.02 50.94 1.97 50.93 2.21
 Female 894 (49.24) 1.23 0.06 0.13 0.39 0.02 0.94 49.06 1.97 49.07 2.21 1.00
Age group, y
 6–11 965 (44.36) 1.28 0.05 0.36 0.02 40.54 2.37 48.40 1.81
 12–19 866 (55.64) 1.24 0.06 0.70 0.39 0.02 0.30 59.46 2.37 51.60 1.81 0.02
Smoke exposured
 Yes 364 (21.72) 1.32 0.07 0.39 0.03 20.12 2.37 23.64 1.62
 No 1330 (78.28) 1.23 0.05 0.89 0.37 0.02 0.29 79.88 2.37 76.36 1.62 0.20
 Missing 137 (6.84) 1.32 0.17 0.56 0.37 0.04 0.48 7.40 1.31 6.41 1.73 0.61
PIR quartile
 First (<0.8) 415 (16.89) 1.40 0.09 0.47 0.03 16.04 1.96 17.96 2.17
 Second (≥0.8 to <1.47) 416 (19.19) 1.30 0.07 0.37 0.04 17.87 1.64 20.87 2.48
 Third (≥1.47 to <2.92) 423 (27.81) 1.23 0.07 0.35 0.03 27.53 1.98 28.15 2.44
 Fourth (≥2.92) 418 (36.11) 1.22 0.08 0.02 0.33 0.02 0.00 38.56 3.26 33.01 3.94 0.31
 Income information missing 159 (8.47) 1.11 0.13 0.43 0.58 0.07 0.00 5.65 1.10 8.30 1.15 0.10
Head of household education level
 <9th Grade 207 (7.80) 1.21 0.14 0.46 0.04 7.24 1.20 8.59 1.78
 ≥9th Grade but less than high school 255 (11.19) 1.33 0.11 0.36 0.04 10.13 1.30 12.68 1.89
 High school graduation 393 (21.39) 1.33 0.08 0.39 0.04 24.12 1.99 17.58 1.46
 Some college or associate’s degree 557 (33.87) 1.28 0.08 0.36 0.03 32.75 2.82 35.21 1.96
 College or more 358 (25.75) 1.15 0.10 0.10 0.36 0.03 0.05 25.75 2.84 24.99 2.95 0.09
 Education information missing 61 (2.97) 1.28 0.21 0.94 0.47 0.07 0.63 2.16 0.75 3.82 0.83 0.18
Race/ethnicity
 Mexican American Hispanic 428 (15.78) 1.24 0.06 0.45 0.03 14.51 2.22 17.45 3.19
 Other Hispanic 206 (7.53) 1.21 0.07 0.54 0.05 5.72 0.73 9.78 1.44
 Non-Hispanic white 487 (53.15) 1.21 0.06 0.31 0.02 56.62 3.67 48.68 5.39
 Non-Hispanic black 440 (14.23) 1.66 0.12 0.50 0.03 15.52 2.31 12.91 2.47
 Other/multiple 270 (9.31) 1.07 0.10 0.00 0.37 0.03 0.00 7.63 1.05 11.17 1.71 0.01
Time spent watching television, h
 <2 675 (40.42) 1.30 0.08 0.36 0.02 40.72 2.76 39.52 2.25
 ≥2 1133 (59.58) 1.25 0.04 0.74 0.39 0.02 0.13 59.28 2.76 60.48 2.25 0.75
 Television watching information missing 23 (1.51) 0.62 0.18 0.08 0.33 0.12 0.38 1.69 0.60 1.12 0.32 0.37
Caloric intakee
 USDA cutpoint or less 1179 (75.86) 1.26 0.05 0.37 0.02 76.52 1.55 74.95 2.10
 Greater than USDA cutpoint 413 (24.14) 1.23 0.09 0.51 0.38 0.04 0.24 23.48 1.55 25.05 2.10 0.59
 Caloric intake information missing 239 (11.33) 1.36 0.12 0.89 0.38 0.04 0.29 11.00 1.55 11.50 1.47 0.83
Obesityf
 Yes 381 (19.55) 1.34 0.08 0.47 0.04 20.77 1.89 18.13 1.95
 No 1439 (80.45) 1.23 0.05 0.17 0.35 0.02 0.00 79.23 1.89 81.87 1.95 0.20
 Missing 11 (0.50) 2.60 1.27 0.63 0.79 0.27 0.21 0.65 0.31 0.25 0.14 0.20
Severe obesityg
 Yes 253 (12.68) 1.33 0.09 0.49 0.05 13.04 1.51 12.39 1.68
 No 1567 (87.32) 1.24 0.05 0.26 0.36 0.02 0.00 86.96 1.51 87.61 1.68 0.74
 Missing 11 (0.50) 2.60 1.27 0.63 0.79 0.27 0.21 0.65 0.31 0.25 0.14 0.20
Abdominal obesityh
 Yes 669 (36.22) 1.26 0.05 0.42 0.03 38.22 2.53 33.75 2.74
 No 1108 (63.78) 1.26 0.05 0.94 0.35 0.02 0.00 61.78 2.53 66.25 2.74 0.11
 Missing 54 (2.86) 1.10 0.27 0.55 0.48 0.12 0.08 3.25 0.58 1.18 0.31 0.00
Overweight or higheri
 Yes 712 (38.22) 1.29 0.06 0.42 0.02 40.64 2.30 35.25 2.21
 No 1108 (61.78) 1.23 0.05 0.19 0.35 0.02 0.00 59.36 2.30 64.75 2.21 0.02
 Missing 11 (0.50) 2.60 1.27 0.63 0.79 0.27 0.21 0.65 0.31 0.25 0.14 0.20
BPA quartile
 First 440 (24.63) 0.37 0.01 0.21 0.01 19.17 1.70 31.35 2.07
 Second 460 (24.62) 0.91 0.01 0.35 0.03 22.65 1.83 27.06 2.18
 Third 454 (24.96) 1.60 0.01 0.45 0.03 26.82 1.89 22.65 1.84
 Fourth 477 (25.79) 4.41 0.10 0.00 0.59 0.04 0.00 31.36 1.76 18.94 1.70 0.00

Abbreviations: GM, geometric mean; GSE, geometric standard error; USDA, US Department of Agriculture.

a

All cell counts provided are unweighted, with percentages weighted to NHANES environmental subsample.

b

P values generated from Mann-Whitney U tests for dichotomous variables and Kruskal-Wallis H tests for variables with two or more categories.

c

P values generated from χ2 tests.

d

Composite variable consisting of serum cotinine concentrations ≥2 ng/mL for 2013 to 2014 and questionnaire proxies for 2015 to 2016.

e

USDA cut point for children with high physical activity.

f

Obesity defined as ≥95th percentile of age- and sex-standardized BMI z-scores.

g

Severe obesity defined as ≥120% of the 95th percentile of age- and sex-standardized BMI z-scores or a BMI of ≥35 kg/m2greater, whichever was lower.

h

Defined as waist circumference (cm)/height (cm) ≥0.5.

i

Overweight defined as ≥85th percentile of age- and sex-standardized body mass index (BMI) z-scores.

The overall prevalence of general obesity among those aged 6 to 19 years between 2013 and 2016 was 19.6% and of severe obesity was 12.7%. Abdominal obesity was more common (36.2%). In bivariate analyses, the BPS levels were greater among those who were obese (0.47 vs 0.35 ng/mL among nonobese; P < 0.01), severely obese (0.49 vs 0.36 ng/mL; P < 0.01), or abdominally obese (0.42 vs 0.35 among nonabdominally obese; P < 0.01). For BPA, although the estimates appeared in this same direction for obese vs not obese, the difference was not statistically significant (1.34 vs 1.23; P = 0.17). BPF detection was not significantly associated with any obesity measure, but it was associated with being overweight or higher (P = 0.02). BPA correlated positively with both BPS (Spearman ρ = 0.35) and BPF (Spearman ρ = 0.24; P < 0.01).

In models controlling for creatinine only, BPS was associated with an increased odds of general obesity (OR, 1.19; 95% CI, 1.04 to 1.37; Table 2). Although the point estimates for BPA, total bisphenols, and BPF detection were greater than one, they were not statistically significant (Tables 2 and 3). These associations did not materially vary across most demographic or behavioral variable strata. However, the estimates tended to be greater for boys than for girls for BPA, BPF detection, and total bisphenol concentrations (Tables 2 and 3). In addition, the estimates among those of other or multiple races were elevated compared with those of all other race/ethnicities for BPA, BPF detection, and total bisphenol concentrations.

Table 2.

Associations of Natural Log-Transformed Urinary BPS and BPA and Total Bisphenols and Obesitya Adjusted for Urinary Creatinine Concentrations in Strata Defined by Sample Characteristics

Characteristic Prevalence of Obesitya ln (BPS Concentration) ln (BPA Concentration) ln (Total Bisphenols)
Obese/Total (Unweighted) Obese in Stratum, % SE OR 95% CI OR 95% CI OR 95% CI
Entire sample 381/1820 19.55 1.58 1.19 1.04–1.37 1.04 0.88–1.22 1.06 0.94–1.21
Sex
 Male 205/935 19.56 2.19 1.18 0.99–1.42 1.09 0.93–1.28 1.12 0.95–1.31
 Female 176/885 19.53 1.76 1.22 1.01–1.48 0.98 0.72–1.34 1.00 0.79–1.26
Age group, y
 6–11 193/962 17.59 1.61 1.25 1.03–1.51 1.00 0.80–1.26 1.04 0.82–1.33
 12–19 188/858 21.11 2.28 1.18 0.98–1.42 1.10 0.89–1.35 1.08 0.93–1.27
Smoke exposureb
 Yes 80/361 22.40 3.89 1.15 0.79–1.66 0.95 0.70–1.29 1.17 0.91–1.51
 No 280/1323 19.46 1.61 1.20 1.03–1.39 1.06 0.88–1.28 1.03 0.88–1.21
PIR
 Less than median (1.47) 201/827 23.80 1.73 1.06 0.92–1.23 0.92 0.73–1.16 1.02 0.86–1.20
 Median or greater 146/837 16.97 2.02 1.27 1.03–1.58 1.08 0.86–1.36 1.07 0.87–1.31
Head of household education level
 High school or less 215/848 25.25 2.15 1.07 0.89–1.29 0.96 0.83–1.12 1.05 0.86–1.27
 Some college or more 160/913 15.97 1.66 1.28 1.07–1.54 1.01 0.78–1.31 1.02 0.82–1.25
Race/ethnicity
 Hispanic 166/629 26.90 1.52 1.21 1.06–1.38 1.18 0.99–1.41 1.22 1.02–1.46
 Non-Hispanic white 78/486 15.84 2.40 1.15 0.91–1.47 1.01 0.76–1.34 0.93 0.76–1.13
 Non-Hispanic black 96/439 22.68 2.84 1.05 0.83–1.33 0.71 0.44–1.15 0.93 0.67–1.27
 Other/multiple 41/266 17.62 3.09 1.14 0.70–1.84 1.30 0.83–2.03 1.73 1.10–2.72
Time spent watching television, h
 <2 115/693 15.57 1.98 1.27 1.05–1.53 1.12 0.84–1.50 0.99 0.78–1.26
 ≥2 266/1127 22.35 1.92 1.14 0.96–1.36 1.00 0.83–1.20 1.11 0.92–1.34
Caloric intakec
 USDA cutpoint or less 293/1408 19.13 1.65 1.23 1.06–1.43 1.04 0.83–1.29 1.10 0.96–1.26
 Greater than USDA cutpoint 88/412 21.08 3.34 1.05 0.78–1.42 1.03 0.75–1.41 0.93 0.66–1.31

Abbreviation: USDA, US Department of Agriculture.

a

Obesity defined as ≥95th percentile of age- and sex-standardized BMI z-scores.

b

Composite variable consisting of serum cotinine concentrations ≥2 ng/mL for 2013 to 2014 and questionnaire proxies for 2015 to 2016.

c

USDA cutpoint for children with high physical activity.

Table 3.

Associations of BPF Detection and Obesitya Adjusted for Urinary Creatinine Concentrations in Strata Defined by Sample Characteristics

Variable BPF Detection
Less Than LOD (Reference) Greater Than LOD
Obese,a % SE OR 95% CI Obese,a SE
Entire sample 18.13 1.95 1.13 0.87–1.48 20.77 1.89
Sex
 Male 16.34 2.55 1.37 0.94–1.98 22.43 2.60
 Female 19.98 2.32 0.93 0.62–1.40 19.02 2.41
Age group, y
 6–11 17.04 2.22 1.00 0.63–1.60 17.85 2.42
 12–19 19.14 2.51 1.23 0.85–1.76 22.78 2.79
Smoke exposureb
 Yes 19.27 4.78 1.49 0.81–2.74 25.15 4.28
 No 17.99 1.96 1.12 0.83–1.52 20.82 2.15
PIR
 Less than median (1.47) 21.04 2.43 1.28 0.92–1.77 26.31 2.02
 Median or more 14.99 2.54 1.23 0.81–1.88 18.42 2.33
Head of household education level
 High school or less 24.50 2.69 1.07 0.71–1.61 25.86 3.01
 Some college or more 14.13 2.25 1.18 0.78–1.79 17.48 2.04
Race/ethnicity
 Hispanic 27.56 2.33 0.82 0.56–1.22 25.61 2.42
 Non-Hispanic white 13.98 3.25 1.26 0.74–2.14 17.17 2.67
 Non-Hispanic black 18.90 3.21 1.36 0.82–2.27 25.53 3.69
 Other/multiple 12.39 2.64 2.44 1.24–4.79 25.07 5.53
Time spent watching television, h
 <2 16.21 2.59 0.89 0.52–1.52 15.11 2.69
 ≥2 19.48 2.25 1.29 0.91–1.82 24.63 2.51
Caloric intakec
 USDA cutpoint or less 17.78 2.09 1.12 0.81–1.54 20.28 2.03
 Greater than USDA cutpoint 19.34 3.59 1.18 0.68–2.05 22.61 4.41

Abbreviation: USDA, US Department of Agriculture.

a

Obesity defined as ≥95th percentile of age- and sex-standardized BMI z-scores.

b

Composite variable consisting of serum cotinine concentrations ≥2 ng/mL for 2013 to 2014 and questionnaire proxies for 2015 to 2016.

c

USDA cutpoint for children with high physical activity.

In the adjusted models, log-transformed continuous BPS concentrations were associated with increased odds of general obesity, severe obesity, and abdominal obesity (Table 4). For each log-unit increase in BPS, the odds of general obesity increased by 16% (OR, 1.16; 95% CI, 1.02 to 1.32), severe obesity by 18% (OR, 1.18; 95% CI, 1.03 to 1.35), and abdominal obesity by 13% (OR, 1.13; 95% CI, 1.02 to 1.27). The association between log-transformed BPS and the continuous BMI z-score was nearly statistically significant (β = 0.06; 95% CI, −0.01 to 0.12). However, the BPS quartiles were not significantly associated statistically with any outcome, although the estimates were greater than one and had increased in magnitude as the quartiles increased. In addition, although BPF detection (vs less than the LOD) was not significantly associated statistically with general or severe obesity, it was with an increased odds of overweight (OR, 1.27; 95% CI, 1.06 to 1.51) and abdominal obesity (OR, 1.29; 95% CI, 1.01 to 1.64) and an increase in the BMI z-score (β = 0.10; 95% CI, 0.01 to 0.20).

Table 4.

Associations of Urinary BPS, BPF, BPA, and Total Bisphenol Concentrations and Body Mass Outcomes From Multivariable Modelsa

Variable Obesityb Severe Obesityc Abdominal Obesityd Overweighte BMI Z-Score
OR 95% CI OR 95% CI OR 95% CI OR 95% CI β 95% CI
ln(BPS)f 1.16 1.02–1.32 1.18 1.03–1.35 1.13 1.02–1.27 1.09 0.99–1.19 0.06 −0.01 to 0.12
BPS quartile
 Second vs first 0.96 0.65–1.41 1.25 0.84–1.87 0.99 0.72–1.37 1.02 0.71–1.48 0.08 −0.09 to 0.24
 Third vs first 1.17 0.73–1.89 1.49 0.83–2.66 1.14 0.72–1.80 1.17 0.82–1.68 0.10 −0.13 to 0.34
 Fourth vs first 1.43 0.89–2.32 1.62 0.95–2.75 1.33 0.91–1.96 1.16 0.81–1.65 0.14 −0.10 to 0.37
BPF detected (vs less than LOD) 1.18 0.92–1.52 1.03 0.72–1.48 1.29 1.01–1.64 1.27 1.06–1.51 0.10 0.01 to 0.20
ln(BPA)f 1.04 0.88–1.22 0.99 0.82–1.18 1.00 0.88–1.15 1.01 0.88–1.17 −0.03 −0.13 to 0.06
BPA quartile
 Second vs first 1.29 0.88–1.87 1.57 0.96–2.57 0.99 0.72–1.37 1.1 0.8–1.51 0.08 −0.08 to 0.24
 Third vs first 1.09 0.67–1.77 1.04 0.62–1.76 1.15 0.81–1.63 1.38 0.91–2.1 0.16 −0.03 to 0.36
 Fourth vs first 1.30 0.83–2.02 1.14 0.61–2.15 1.24 0.87–1.78 1.24 0.84–1.85 −0.01 −0.25 to 0.23
ln(total bisphenol)f 1.06 0.93–1.21 1.02 0.85–1.23 1.05 0.95–1.15 1.03 0.94–1.14 −0.01 −0.09 to 0.08
Total bisphenol quartile
 Second vs first 1.14 0.78–1.68 1.34 0.83–2.15 0.99 0.77–1.27 1.05 0.76–1.45 0.16 −0.01 to 0.32
 Third vs first 0.97 0.67–1.39 0.90 0.54–1.5 1.19 0.83–1.71 1.07 0.74–1.53 0.07 −0.12 to 0.26
 Fourth vs first 1.32 0.87–2.00 1.24 0.71–2.18 1.19 0.84–1.67 1.16 0.83–1.61 0.04 −0.19 to 0.28
a

Models controlled for urinary creatinine, sex, age, race/ethnicity, smoke exposure, PIR, head of household education level, time spent watching television, and caloric intake.

b

Obesity defined as ≥95th percentile of age- and sex-standardized BMI z-scores.

c

Severe obesity defined as ≥120% of the 95th percentile of age- and sex-standardized BMI z-scores or a BMI of ≥35 kg/m2, whichever was lower.

d

Abdominal obesity defined as ratio between waist circumference and height ≥0.5.

e

Overweight defined as ≥85th percentile of age- and sex-standardized BMI z-scores.

f

Change in the respective outcome associated with a log-unit increase in each corresponding bisphenol concentration.

Neither BPA nor total bisphenols, when expressed as log-transformed continuous variables or as quartiles, were significantly associated statistically with any body mass outcomes, although the estimates were generally greater than one.

3. Discussion

The present study has documented a modest positive association between BPS and increases in standardized body mass index measures (i.e., obesity and severe obesity) in a representative US sample of children and adolescents. The association was most apparent when BPS was considered as a log-transformed continuous variable vs as quartiles. The BPS concentrations and BPF detection were also associated with abdominal obesity. Finally, BPF was positively associated with overweight and an increase in BMI z-scores overall. However, BPA was not significantly associated with any body mass outcome.

Just as with the previous studies of this topic [11, 12], our results should be interpreted with caution. The cross-sectional design precluded our ability to infer whether exposure to bisphenols might influence weight gain or obesity or whether obese children might have greater exposure to, or excretion of, bisphenol compounds. The methodologic issues involved in the study of this relationship have been well described [23]. One key issue is that BPS and BPF are metabolized rapidly by the human body [24, 25]; thus, spot urine samples are limited in their ability to reflect long-term exposure levels [26, 27]. This is problematic when assessing these chemicals in relation to obesity, which occurs incrementally over time and has a multifactorial etiology [28]. Finally, the situation is further complicated because food and beverage packaging, in particular, the lining of aluminum cans, contains bisphenols. Therefore, those who consume more of these products are more likely to have higher exposure levels [29, 30] and, perhaps, are more likely to be obese [31–34]. However, one method we used to account for this was to adjust for caloric intake, which did not substantially alter the estimates (data not shown). Nonetheless, taken together, these issues make it difficult to infer a causative relationship between bisphenol chemicals and obesity. However, owing to the repeated observations of this association in both cross-sectional [11, 12, 35–40] and longitudinal [41, 42] studies and the biologic plausibility and evidence from toxicological studies [10, 43, 44], the potentially obesogenic influences of bisphenol chemicals merits further attention and examination.

Although the associations between BPA, total bisphenol, and BPF detection and general obesity were not statistically significant, we noted potential heterogeneity in the measures of association across the strata of race/ethnicity. For example, boys and those of other or multiple races tended to have slightly stronger associations between bisphenols and general obesity compared with those of the other subgroups (i.e., girls and those of all other race/ethnicities). In contrast, our previous work showed that the associations between BPA and obesity were concentrated among non-Hispanic whites [11]. Differences across racial and/or ethnic groups could be explained, in part, by the different exposure patterns [45] or potential interactions with unmeasured behavioral [46], genetic, or epigenetic [47] differences. However, these associations and differences by race/ethnicity found in the present study were not statistically significant; thus, these potential explanations are solely hypothesis generating.

As BPA levels have declined, the use of BPS and its detection in human samples has increased in recent years [48]. Therefore, as the associations between BPA and obesity have attenuated as BPA levels have declined, it is possible that the associations between BPS and body mass could change as the levels increase. In our previous work on BPA and obesity among children in NHANES 2003 to 2008 [11], the median urinary BPA concentration was 2.8 ng/mL (interquartile range, 1.5 to 5.6), an order of magnitude greater than the current BPS levels in the present study. Thus, the potential health effects of BPS and other BPA replacement compounds should continue to be monitored, given that human exposure to these compounds is likely to continue to increase in the future.

Acknowledgments

Financial Support: The present study was supported by the National Institutes of Environmental Health Sciences (grants R01ES022972, R01ES029779, and P30 ES000260 to M.J., M.W., L.T. and grant P30 ES005605 to W.B. and B.L.).

Glossary

Abbreviations:

BMI

body mass index

BPA

bisphenol A

BPF

bisphenol F

BPS

bisphenol S

LOD

limit of detection

NHANES

US National Health and Nutrition Examination Surveys

PIR

poverty/income ratio

Additonal Information

Disclosure Summary: The authors have nothing to disclose.

Data Availability:

All data generated or analyzed during this study are included in the present report or in the data repositories listed in the references.

References and Notes

  • 1. Hoepner LA. Bisphenol A: a narrative review of prenatal exposure effects on adipogenesis and childhood obesity via peroxisome proliferator-activated receptor gamma. Environ Res. 2019;173:54–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Rubin BS, Schaeberle CM, Soto AM. The case for BPA as an obesogen: contributors to the controversy. Front Endocrinol (Lausanne). 2019;10:30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Masuno H, Kidani T, Sekiya K, Sakayama K, Shiosaka T, Yamamoto H, Honda K. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res. 2002;43(5):676–684. [PubMed] [Google Scholar]
  • 4. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect. 2008;116(12):1642–1647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Ben-Jonathan N, Hugo ER, Brandebourg TD. Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol Cell Endocrinol. 2009;304(1-2):49–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Legler J, Fletcher T, Govarts E, Porta M, Blumberg B, Heindel JJ, Trasande L. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100(4):1278–1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Trasande L. Exploring regrettable substitution: replacements for bisphenol A. Lancet Planet Health. 2017;1(3):e88–e89. [DOI] [PubMed] [Google Scholar]
  • 8. Chen M-Y, Ike M, Fujita M. Acute toxicity, mutagenicity, and estrogenicity of bisphenol-A and other bisphenols. Environ Toxicol. 2002;17(1):80–86. [DOI] [PubMed] [Google Scholar]
  • 9. Yamasaki K, Takeyoshi M, Yakabe Y, Sawaki M, Imatanaka N, Takatsuki M. Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. Toxicology. 2002;170(1-2):21–30. [DOI] [PubMed] [Google Scholar]
  • 10. Drobna Z, Talarovicova A, Schrader HE, Fennell TR, Snyder RW, Rissman EF. Bisphenol F has different effects on preadipocytes differentiation and weight gain in adult mice as compared with Bisphenol A and S. Toxicology. 2019;420:66–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA. 2012;308(11):1113–1121. [DOI] [PubMed] [Google Scholar]
  • 12. Liu B, Lehmler HJ, Sun Y, Xu G, Sun Q, Snetselaar LG, Wallace RB, Bao W. Association of bisphenol A and its substitutes, bisphenol F and bisphenol S, with obesity in United States children and adolescents. Diabetes Metab J. 2019;43(1):59–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. Available at: www.cdc.gov/nchs/nhanes/index.htm. Accessed 24 April 2019.
  • 14. Centers for Disease Control and Prevention, National Center for Health Statistics. Laboratory Procedure Manual, Personal Care and Consumer Product Chemicals and Metabolites: Benzophenone-3, Bisphenol A, Bisphenol F, Bisphenol S, 2,4-Dichlorophenol, 2,5-Dichlorophenol, Methyl-, Ethyl-, Propyl-, and Butyl Parabens, Triclosan, and Triclocarban. 2015-16. Available at: https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/labmethods/EPHPP_I_MET.pdf. Accessed 24 April 2019.
  • 15. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES): Anthropometry Procedures Manual. Bethesda, MD: Centers for Disease Control and Prevention; 2013. [Google Scholar]
  • 16. Kuczmarski RJ. 2000 CDC growth charts for the United States; methods and development. Vital Health Stat. 2002;May(246):1–190. [PubMed] [Google Scholar]
  • 17. Kuczmarski RJ. CDC growth charts: United States Adv Data. 2000;Jun(314):1–27. [PubMed] [Google Scholar]
  • 18. Ogden CL, Flegal KMJA. Changes in terminology for childhood overweight and obesity. Natl Health Stat Report. 2010;Jun(25):1–5. [PubMed] [Google Scholar]
  • 19. Skinner AC, Skelton JA. Prevalence and trends in obesity and severe obesity among children in the United States, 1999-2012. JAMA Pediatr. 2014;168(6):561–566. [DOI] [PubMed] [Google Scholar]
  • 20. Li C, Ford ES, Mokdad AH, Cook SJP. Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics. 2006;118(5):e1390–e1398. [DOI] [PubMed] [Google Scholar]
  • 21. Chen T-C, Parker JD, Clark J, Shin H-C, Rammon JR, Burt VL. National health and nutrition examination survey: estimation procedures, 2011–2014. Vital Health Stat 2. 2018;Jan(177):1–26. [PubMed] [Google Scholar]
  • 22. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey: Analytic Guidelines, 2011-2016. Available at: https://wwwn.cdc.gov/nchs/data/nhanes/2011-2012/analyticguidelines/analytic_guidelines_11_16.pdf. Accessed 24 April 2019. [Google Scholar]
  • 23. Hatch EE, Nelson JW, Stahlhut RW, Webster TF. Association of endocrine disruptors and obesity: perspectives from epidemiological studies. Int J Androl. 2010;33(2):324–332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Rochester JR, Bolden AL. Bisphenol S and F: a systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ Health Perspect. 2015;123(7):643–650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Oh J, Choi JW, Ahn Y-A, Kim S. Pharmacokinetics of bisphenol S in humans after single oral administration. Environ Int. 2018;112:127–133. [DOI] [PubMed] [Google Scholar]
  • 26. Casas M, Basagaña X, Sakhi AK, Haug LS, Philippat C, Granum B, Manzano-Salgado CB, Brochot C, Zeman F, de Bont J, Andrusaityte S, Chatzi L, Donaire-Gonzalez D, Giorgis-Allemand L, Gonzalez JR, Gracia-Lavedan E, Grazuleviciene R, Kampouri M, Lyon-Caen S, Pañella P, Petraviciene I, Robinson O, Urquiza J, Vafeiadi M, Vernet C, Waiblinger D, Wright J, Thomsen C, Slama R, Vrijheid M. Variability of urinary concentrations of non-persistent chemicals in pregnant women and school-aged children. Environ Int. 2018;121(Pt 1):561–573. [DOI] [PubMed] [Google Scholar]
  • 27. Teitelbaum S, Britton J, Calafat A, Ye X, Silva MJ, Reidy JA, Galvez MP, Brenner BL, Wolff MS. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ Res. 2008;106(2):257–269. [DOI] [PubMed] [Google Scholar]
  • 28. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet. 2002;360(9331):473–482. [DOI] [PubMed] [Google Scholar]
  • 29. Hartle JC, Navas-Acien A, Lawrence RS. The consumption of canned food and beverages and urinary bisphenol A concentrations in NHANES 2003–2008. Environ Res. 2016;150:375–382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Rudel RA, Gray JM, Engel CL, Rawsthorne TW, Dodson RE, Ackerman JM, Rizzo J, Nudelman JL, Brody JG. Food packaging and bisphenol A and bis (2-ethyhexyl) phthalate exposure: findings from a dietary intervention. Environ Health Perspect. 2011;119(7):914–920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Ludwig DS, Nestle M. Can the food industry play a constructive role in the obesity epidemic? JAMA. 2008;300(15):1808–1811. [DOI] [PubMed] [Google Scholar]
  • 32. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–814. [DOI] [PubMed] [Google Scholar]
  • 33. Pereira MA, Kartashov AI, Ebbeling CB, Van Horn L, Slattery ML, Jacobs DR Jr, Ludwig DS. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet. 2005;365(9453):36–42. [DOI] [PubMed] [Google Scholar]
  • 34. Canella DS, Levy RB, Martins APB, Claro RM, Moubarac JC, Baraldi LG, Cannon G, Monteiro CA. Ultra-processed food products and obesity in Brazilian households (2008-2009). PLoS One. 2014;9(3):e92752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Wells EM, Jackson LW, Koontz MB. Association between bisphenol A and waist-to-height ratio among children: National Health and Nutrition Examination Survey, 2003–2010. Ann Epidemiol. 2014;2(24):165–167. [DOI] [PubMed] [Google Scholar]
  • 36. Wang H-x, Zhou Y, Tang C-x, Wu J-g, Chen Y, Jiang QW. Association between bisphenol A exposure and body mass index in Chinese school children: a cross-sectional study. Environ Health. 2012;11(1):79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Li D-K, Miao M, Zhou Z, Wu C, Shi H, Liu X, Wang S, Yuan W. Urine bisphenol-A level in relation to obesity and overweight in school-age children. PLoS One. 2013;8(6):e65399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Bhandari R, Xiao J, Shankar A. Urinary bisphenol A and obesity in US children. Am J Epidemiol. 2013;177(11):1263–1270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Eng DS, Lee JM, Gebremariam A, Meeker JD, Peterson K, Padmanabhan VJP. Bisphenol A and chronic disease risk factors in US children. Pediatrics. 2013;132(3):e637–e645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Harley KG, Aguilar Schall R, Chevrier J, Tyler K, Aguirre H, Bradman A, Holland NT, Lustig RH, Calafat AM, Eskenazi B. Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ Health Perspect. 2013;121(4):514–520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Valvi D, Casas M, Mendez MA, Ballesteros-Gómez A, Luque N, Rubio S, Sunyer J, Vrijheid M. Prenatal bisphenol a urine concentrations and early rapid growth and overweight risk in the offspring. Epidemiology. 2013;24(6):791–799. [DOI] [PubMed] [Google Scholar]
  • 42. Song Y, Hauser R, Hu F, Franke A, Liu S, Sun Q. Urinary concentrations of bisphenol A and phthalate metabolites and weight change: a prospective investigation in US women. Int J Obes (Lond). 2014;38(12):1532–1537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Song S, Zhang L, Zhang H, Wei W, Jia L. Perinatal BPA exposure induces hyperglycemia, oxidative stress and decreased adiponectin production in later life of male rat offspring. Int J Environ Res Public Health. 2014;11(4):3728–3742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Aboul Ezz HS, Khadrawy YA, Mourad IM. The effect of bisphenol A on some oxidative stress parameters and acetylcholinesterase activity in the heart of male albino rats. Cytotechnology. 2015;67(1):145–155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Lehmler H-J, Liu B, Gadogbe M, Bao W. Exposure to bisphenol A, bisphenol F, and bisphenol S in U.S. adults and children: the National Health and Nutrition Examination Survey 2013-2014. ACS Omega. 2018;3(6):6523–6532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Stacy SL, Eliot M, Calafat AM, Chen A, Lanphear BP, Hauser R, Papandonatos GD, Sathyanarayana S, Ye X, Yotlon K, Braun JM. Patterns, variability, and predictors of urinary bisphenol A concentrations during childhood. Environ Sci Technol. 2016;50(11):5981–5990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Bollati V, Baccarelli AJH. Environmental epigenetics. Heridty (Edinb). 2010;105(1):105–112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Ye X, Wong L-Y, Kramer J, Zhou X, Jia T, Calafat AM. Urinary concentrations of bisphenol A and three other bisphenols in convenience samples of U.S. adults during 2000-2014. Environ Sci Technol. 2015;49(19):11834–11839. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analyzed during this study are included in the present report or in the data repositories listed in the references.


Articles from Journal of the Endocrine Society are provided here courtesy of The Endocrine Society

RESOURCES